Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
36.20
-0.17 (-0.47%)
At close: May 13, 2025, 4:00 PM
36.53
+0.33 (0.91%)
Pre-market: May 14, 2025, 7:00 AM EDT

Sarepta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,55811,6149,02111,3757,84113,454
Upgrade
Market Cap Growth
-49.03%28.75%-20.70%45.06%-41.72%39.87%
Upgrade
Enterprise Value
4,39211,8318,67710,9077,42012,422
Upgrade
Last Close Price
36.20121.5996.43129.5890.05170.49
Upgrade
PE Ratio
-49.37----
Upgrade
Forward PE
10.7515.47----
Upgrade
PS Ratio
1.556.117.2612.1911.1724.91
Upgrade
PB Ratio
3.117.6010.5029.558.4517.66
Upgrade
P/TBV Ratio
3.197.7410.8730.148.5817.98
Upgrade
P/FCF Ratio
-----532.53
Upgrade
P/OCF Ratio
-----125.19
Upgrade
EV/Sales Ratio
1.976.226.9811.6910.5723.00
Upgrade
EV/EBITDA Ratio
-46.25----
Upgrade
EV/EBIT Ratio
-54.25----
Upgrade
EV/FCF Ratio
-----491.69
Upgrade
Debt / Equity Ratio
1.190.881.614.201.231.41
Upgrade
Debt / EBITDA Ratio
39.653.74----
Upgrade
Debt / FCF Ratio
-----42.47
Upgrade
Asset Turnover
0.670.530.390.300.230.23
Upgrade
Inventory Turnover
2.712.103.905.214.123.90
Upgrade
Quick Ratio
2.062.743.233.635.054.99
Upgrade
Current Ratio
4.024.203.954.135.755.97
Upgrade
Return on Equity (ROE)
-23.61%19.71%-86.15%-107.16%-49.57%-70.14%
Upgrade
Return on Assets (ROA)
-2.19%3.77%-5.24%-10.68%-9.04%-14.67%
Upgrade
Return on Capital (ROIC)
-3.02%5.34%-7.90%-16.47%-14.21%-20.84%
Upgrade
Return on Capital Employed (ROCE)
-6.70%----
Upgrade
Earnings Yield
-6.98%2.02%-5.94%-6.19%-5.34%-4.12%
Upgrade
FCF Yield
-19.54%-2.95%-6.40%-3.13%-6.14%0.19%
Upgrade
Buyback Yield / Dilution
-0.83%-16.75%-5.53%-7.75%-4.24%-5.90%
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q